mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |